Grazyna Sypniewska
Overview
Explore the profile of Grazyna Sypniewska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1093
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gajewski P, Krintus M, Chudas K, Pawlowski R, Laskowska E, Jasiewicz M, et al.
EJIFCC
. 2024 May;
35(1):10-22.
PMID: 38706733
Background: BD Barricor tubes have been proposed to decrease laboratory turnaround time (TAT). We analytically validated and then clinically verified these tubes for use with Abbott Alinity and Siemens Atellica...
2.
Kloska S, Kozinski M, Stefanska A, Bergmann K, Mankowska-Cyl A, Siodmiak J, et al.
J Med Biochem
. 2023 Dec;
42(4):665-674.
PMID: 38084246
Background: Cardiac myosin-binding protein C (cMyC) is a novel cardio-specific biomarker of potential diagnostic and prognostic value for cardiovascular events. This study aims to determine reference values for cMyC and...
3.
Bergmann K, Stefanska A, Krintus M, Szternel L, Bilinski W, Paradowski P, et al.
Nutrients
. 2023 Aug;
15(16).
PMID: 37630857
Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD)-a new definition for non-alcoholic fatty liver disease-reflects the impact of metabolic abnormalities on liver function. We assessed the diagnostic accuracy of biomarker-based scores...
4.
Bergmann K, Stefanska A, Krintus M, Sypniewska G
Nutr Metab Cardiovasc Dis
. 2023 May;
33(7):1429-1436.
PMID: 37169665
Background And Aims: Lipoprotein(a) is a recognized independent cardiovascular risk factor and apolipoprotein B (apoB) level better reflects the risk than LDL-cholesterol. Despite this cardiovascular prediction mostly relies on traditional...
5.
Bergmann K, Stefanska A, Krintus M, Szternel L, Panteghini M, Sypniewska G
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36674606
Elevated liver enzyme activity may be associated with metabolic syndrome (MetS); however, it is not included in the MetS definition for children. Postprandial changes in the levels of biochemistry tests...
6.
Stefanska A, Bergmann K, Krintus M, Kuligowska-Prusinska M, Murawska K, Sypniewska G
Metabolites
. 2022 Jun;
12(6).
PMID: 35736472
Angiopoietin-like proteins ANGPTL3 and ANGPTL8 have been shown to inhibit lipoprotein lipase, and thus regulate triglyceride level in the circulation. Whether the regulation of lipid metabolism by ANGPTLs is affected...
7.
Kubacka J, Staniszewska M, Sadok I, Sypniewska G, Stefanska A
Metabolites
. 2022 Jun;
12(6).
PMID: 35736425
We examined the relationships of tryptophan (Trp) and the metabolites of the kynurenine pathway (KP) to the occurrence of type 2 diabetes (T2D) and metabolic risk factors in obese middle-aged...
8.
Bilinski W, Stefanska A, Szternel L, Bergmann K, Siodmiak J, Krintus M, et al.
Nutrients
. 2022 Mar;
14(6).
PMID: 35334861
The associations between individual components of metabolic syndrome (MetS) and bone health in children are complex, and data on this topic are sparse and inconsistent. We assessed the relationship between...
9.
Murawska K, Krintus M, Kuligowska-Prusinska M, Szternel L, Stefanska A, Sypniewska G
Nutrients
. 2021 Dec;
13(12).
PMID: 34959891
Hypertriglyceridemia is an independent risk factor for coronary artery disease. Lipoprotein lipase (LPL) plays an essential role in the metabolism of triglyceride-rich lipoproteins (TRLs). Angiopoietin-like proteins ANGPTL3 and ANGPTL8 are...
10.
Banach M, Burchardt P, Chlebus K, Dobrowolski P, Dudek D, Dyrbus K, et al.
Arch Med Sci
. 2021 Dec;
17(6):1447-1547.
PMID: 34900032
No abstract available.